• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成核依赖性tau蛋白纤维形成:二聚化的重要性及基本速率常数的估计

Nucleation-dependent tau filament formation: the importance of dimerization and an estimation of elementary rate constants.

作者信息

Congdon Erin E, Kim Sohee, Bonchak Jonathan, Songrug Tanakorn, Matzavinos Anastasios, Kuret Jeff

机构信息

Center for Molecular Neurobiology, Department of Molecular and Cellular Biochemistry, The Ohio State University, Columbus, Ohio 43210, USA.

出版信息

J Biol Chem. 2008 May 16;283(20):13806-16. doi: 10.1074/jbc.M800247200. Epub 2008 Mar 21.

DOI:10.1074/jbc.M800247200
PMID:18359772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2376241/
Abstract

Filamentous inclusions composed of the microtubule-associated protein tau are found in Alzheimer disease and other tauopathic neurodegenerative diseases, but the mechanisms underlying their formation from full-length protein monomer under physiological conditions are unclear. To address this issue, the fibrillization of recombinant full-length four-repeat human tau was examined in vitro as a function of time and submicromolar tau concentrations using electron microscopy assay methods and a small-molecule inducer of aggregation, thiazine red. Data were then fit to a simple homogeneous nucleation model with rate constant constraints established from filament dissociation rate, critical concentration, and mass-per-unit length measurements. The model was then tested by comparing the predicted time-dependent evolution of length distributions to experimental data. Results indicated that once assembly-competent conformations were attained, the rate-limiting step in the fibrillization pathway was tau dimer formation. Filament elongation then proceeded by addition of tau monomers to nascent filament ends. Filaments isolated at reaction plateau contained approximately 2 tau protomers/beta-strand spacing on the basis of mass-per-unit length measurements. The model suggests four key steps in the aggregation pathway that must be surmounted for tau filaments to form in disease.

摘要

由微管相关蛋白tau组成的丝状内含物在阿尔茨海默病和其他tau蛋白病性神经退行性疾病中被发现,但在生理条件下其从全长蛋白单体形成的潜在机制尚不清楚。为了解决这个问题,使用电子显微镜检测方法和一种聚集小分子诱导剂噻嗪红,体外研究了重组全长四重复人tau的纤维化过程,该过程是时间和亚微摩尔tau浓度的函数。然后将数据拟合到一个简单的均匀成核模型,该模型具有根据丝解离速率、临界浓度和单位长度质量测量建立的速率常数约束。然后通过将预测的长度分布随时间的演变与实验数据进行比较来测试该模型。结果表明,一旦获得具有组装能力的构象,纤维化途径中的限速步骤就是tau二聚体的形成。然后通过向新生丝末端添加tau单体来进行丝的延长。根据单位长度质量测量,在反应平台期分离的丝在每个β链间距中大约含有2个tau原纤维。该模型表明了聚集途径中的四个关键步骤,tau丝要在疾病中形成就必须克服这些步骤。

相似文献

1
Nucleation-dependent tau filament formation: the importance of dimerization and an estimation of elementary rate constants.成核依赖性tau蛋白纤维形成:二聚化的重要性及基本速率常数的估计
J Biol Chem. 2008 May 16;283(20):13806-16. doi: 10.1074/jbc.M800247200. Epub 2008 Mar 21.
2
Pseudophosphorylation of tau protein directly modulates its aggregation kinetics.tau蛋白的假磷酸化直接调节其聚集动力学。
Biochim Biophys Acta. 2011 Feb;1814(2):388-95. doi: 10.1016/j.bbapap.2010.10.005. Epub 2010 Oct 23.
3
Triggers of full-length tau aggregation: a role for partially folded intermediates.全长tau蛋白聚集的触发因素:部分折叠中间体的作用。
Biochemistry. 2005 Apr 19;44(15):5862-72. doi: 10.1021/bi0500123.
4
Cyanine dye N744 inhibits tau fibrillization by blocking filament extension: implications for the treatment of tauopathic neurodegenerative diseases.花菁染料N744通过阻断纤维延伸来抑制tau蛋白纤维化:对tau蛋白病神经退行性疾病治疗的启示
Biochemistry. 2005 Aug 2;44(30):10227-37. doi: 10.1021/bi050387o.
5
Evidence for an intermediate in tau filament formation.tau蛋白细丝形成过程中存在中间体的证据。
Biochemistry. 2004 Feb 17;43(6):1704-14. doi: 10.1021/bi036034b.
6
Quantitative characterization of heparin binding to Tau protein: implication for inducer-mediated Tau filament formation.肝素与 Tau 蛋白结合的定量特征:对诱导剂介导的 Tau 丝形成的影响。
J Biol Chem. 2010 Feb 5;285(6):3592-3599. doi: 10.1074/jbc.M109.035691. Epub 2009 Dec 3.
7
Potency of a tau fibrillization inhibitor is influenced by its aggregation state.tau蛋白纤维化抑制剂的效力受其聚集状态的影响。
Arch Biochem Biophys. 2007 Sep 1;465(1):127-35. doi: 10.1016/j.abb.2007.05.004. Epub 2007 May 25.
8
The role of annealing and fragmentation in human tau aggregation dynamics.退火和断裂在人 tau 聚集动力学中的作用。
J Biol Chem. 2019 Mar 29;294(13):4728-4737. doi: 10.1074/jbc.RA118.006943. Epub 2019 Feb 11.
9
Protein anatomy: C-tail region of human tau protein as a crucial structural element in Alzheimer's paired helical filament formation in vitro.蛋白质剖析:人tau蛋白的C末端区域作为体外阿尔茨海默病成对螺旋丝形成中的关键结构元件。
Biochemistry. 1998 Feb 17;37(7):1979-88. doi: 10.1021/bi9724265.
10
Protein disulfide isomerase interacts with tau protein and inhibits its fibrillization.蛋白质二硫键异构酶与 tau 蛋白相互作用并抑制其纤维化。
PLoS One. 2013 Oct 2;8(10):e76657. doi: 10.1371/journal.pone.0076657. eCollection 2013.

引用本文的文献

1
Detecting the Undetectable: Advances in Methods for Identifying Small Tau Aggregates in Neurodegenerative Diseases.检测难以检测到的物质:神经退行性疾病中小tau蛋白聚集体鉴定方法的进展
Chembiochem. 2025 Apr 1;26(7):e202400877. doi: 10.1002/cbic.202400877. Epub 2025 Jan 8.
2
Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer's disease.炎性小体将创伤性脑损伤、慢性创伤性脑病和阿尔茨海默病联系起来。
Neural Regen Res. 2025 Jun 1;20(6):1644-1664. doi: 10.4103/NRR.NRR-D-24-00107. Epub 2024 Jul 10.
3
Sedimentation and Laser Light Scattering Methods for Quantifying Synthetic Tau Aggregation Propensity.用于定量分析合成 Tau 聚集倾向的沉降和激光光散射方法。
Methods Mol Biol. 2024;2754:117-129. doi: 10.1007/978-1-0716-3629-9_7.
4
Aggregation, Transmission, and Toxicity of the Microtubule-Associated Protein Tau: A Complex Comprehension.微管相关蛋白 Tau 的聚集、传递和毒性:一个复杂的理解。
Int J Mol Sci. 2023 Oct 9;24(19):15023. doi: 10.3390/ijms241915023.
5
The Adult Neurogenesis Theory of Alzheimer's Disease.阿尔茨海默病的成人神经发生理论。
J Alzheimers Dis. 2023;93(4):1237-1276. doi: 10.3233/JAD-221279.
6
DJ-1 Molecular Chaperone Activity Depresses Tau Aggregation Propensity through Interaction with Monomers.DJ-1 分子伴侣活性通过与单体相互作用抑制 Tau 聚集倾向。
Biochemistry. 2023 Mar 7;62(5):976-988. doi: 10.1021/acs.biochem.2c00581. Epub 2023 Feb 22.
7
A Validated Method to Prepare Stable Tau Oligomers.一种稳定的 Tau 寡聚物的验证方法。
Methods Mol Biol. 2023;2551:203-224. doi: 10.1007/978-1-0716-2597-2_14.
8
Quantifying Oligomer Populations in Real Time during Protein Aggregation Using Single-Molecule Mass Photometry.利用单分子质量光度法实时定量蛋白质聚集过程中的寡聚物种群。
ACS Nano. 2022 Oct 25;16(10):16462-16470. doi: 10.1021/acsnano.2c05739. Epub 2022 Sep 20.
9
N-Amination Converts Amyloidogenic Tau Peptides into Soluble Antagonists of Cellular Seeding.N-氨甲酰化将淀粉样蛋白 Tau 肽转化为细胞播种的可溶性拮抗剂。
ACS Chem Neurosci. 2021 Oct 20;12(20):3928-3938. doi: 10.1021/acschemneuro.1c00528. Epub 2021 Oct 5.
10
An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline.一种依赖于组蛋白去乙酰化酶 6 的监控机制可以抑制 tau 介导的神经退行性病变和认知能力下降。
Nat Commun. 2020 Nov 2;11(1):5522. doi: 10.1038/s41467-020-19317-4.

本文引用的文献

1
Detection and quantification of tau aggregation using a membrane filter assay.使用膜滤器测定法检测和定量tau蛋白聚集
Anal Biochem. 2008 Feb 15;373(2):330-6. doi: 10.1016/j.ab.2007.09.015. Epub 2007 Sep 19.
2
A complex mechanism for inducer mediated tau polymerization.诱导剂介导的tau蛋白聚合的复杂机制。
Biochemistry. 2007 Jul 31;46(30):8838-49. doi: 10.1021/bi700403a. Epub 2007 Jul 4.
3
Aggregation drives "misfolding" in protein amyloid fiber formation.聚集作用在蛋白质淀粉样纤维形成过程中驱动“错误折叠”。
Amyloid. 2007 Jun;14(2):119-31. doi: 10.1080/13506120701260059.
4
Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model.逐步蛋白酶解会释放出tau片段,这些片段会在神经元细胞模型中引发全长tau的阿尔茨海默氏样聚集。
Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10252-7. doi: 10.1073/pnas.0703676104. Epub 2007 May 29.
5
Atomic structures of amyloid cross-beta spines reveal varied steric zippers.淀粉样交叉β脊柱的原子结构揭示了不同的空间拉链。
Nature. 2007 May 24;447(7143):453-7. doi: 10.1038/nature05695. Epub 2007 Apr 29.
6
Tau aggregation and toxicity in a cell culture model of tauopathy.tau蛋白病细胞培养模型中的tau蛋白聚集与毒性
J Biol Chem. 2007 Jun 1;282(22):16454-64. doi: 10.1074/jbc.M700192200. Epub 2007 Apr 11.
7
Accumulation of pathological tau species and memory loss in a conditional model of tauopathy.在tau蛋白病条件模型中病理性tau蛋白物种的积累与记忆丧失
J Neurosci. 2007 Apr 4;27(14):3650-62. doi: 10.1523/JNEUROSCI.0587-07.2007.
8
Granular tau oligomers as intermediates of tau filaments.颗粒状tau寡聚体作为tau细丝的中间体。
Biochemistry. 2007 Mar 27;46(12):3856-61. doi: 10.1021/bi061359o. Epub 2007 Mar 6.
9
Cooperative hydrogen bonding in amyloid formation.淀粉样蛋白形成中的协同氢键作用。
Protein Sci. 2007 Apr;16(4):761-4. doi: 10.1110/ps.062609607. Epub 2007 Feb 27.
10
Characterization of the nanoscale properties of individual amyloid fibrils.单个淀粉样纤维的纳米级特性表征。
Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15806-11. doi: 10.1073/pnas.0604035103. Epub 2006 Oct 12.